Drug Manufacturers - Specialty & Generic · Healthcare
Head of Investor Relations
Head of Investor Relations
UNITED THERAPEUTICS Corp (UTHR)Equibles does not estimate personal net worth.
Get an email with a short summary when UNITED THERAPEUTICS Corp publishes a filing, an earnings call transcript or a press release.
Get UTHR alertsHarrison Silvers is recorded as Head of Investor Relations at UNITED THERAPEUTICS Corp (UTHR). Harrison Silvers has spoken on 2 earnings calls and 2 other investor events across 1 company, most recently for UNITED THERAPEUTICS Corp on August 5, 2026. UNITED THERAPEUTICS Corp is classified in the Drug Manufacturers - Specialty & Generic industry within the Healthcare sector. Other leadership on record at UNITED THERAPEUTICS Corp includes Christopher Causey (Board Member), Christopher Patusky (Board Member), James Edgemond (Board Member) and 7 others.
“It is my pleasure to welcome you to the United Therapeutics Corporation's second quarter 2026 corporate update webcast. Remarks today will include forward-looking statements representing our expectations or beliefs regarding future events.”
“Today we may make some forward-looking statements, and for any risks and uncertainties associated with those statements, would encourage you to look at our latest SEC filings on Forms 10-K and 10-Q.”
“First of all, it's great to see at ATS the community come together in pursuit of better outcomes for patients. Just a really great energy there overall, and particularly in our two breaking news sessions, which were accepted in the clinical trial session on Sunday.”
“It is my pleasure to welcome you to the United Therapeutics Corporation First Quarter 2026 Corporate Update Webcast. Remarks today will include forward-looking statements representing our expectations or beliefs regarding future events.”
Drug Manufacturers - Specialty & Generic · Healthcare
Head of Investor Relations